Tsn Thyroid Cancer Panel
This thyroid cancer blood test panel bundles thyroid function, antibodies, and thyroglobulin-related markers to support trend-based monitoring.
This panel bundles multiple biomarker tests in one order—your report explains how results fit together.
This is a lab panel, meaning you get multiple thyroid-related tests from one blood draw. It is designed for situations where a single number (like TSH) is not enough—especially when you are monitoring thyroid cancer after treatment, trying to understand symptoms with a complex thyroid history, or tracking trends over time.
Do I need this panel?
You may want the Tsn Thyroid Cancer Panel if you are in thyroid cancer surveillance and your care plan depends on tracking tumor-marker trends alongside thyroid hormone replacement status. After thyroidectomy and/or radioactive iodine, your follow-up often hinges on whether thyroglobulin (Tg) stays low, rises, or becomes difficult to interpret because of antibodies.
This panel can also be useful when your symptoms and your “headline” thyroid number do not match. For example, you might feel hyperthyroid or hypothyroid even when TSH looks acceptable, or you may be adjusting levothyroxine (T4) or liothyronine (T3) and need a clearer picture of free hormone levels.
If you are planning pregnancy (or already pregnant) and you have a thyroid cancer history or autoimmune thyroid disease, a broader thyroid panel can help you and your clinician confirm that thyroid hormone levels are appropriate for that stage of life and that monitoring is consistent.
This panel is meant to support clinician-directed decisions and trend monitoring. It does not diagnose thyroid cancer by itself, and you should not change thyroid medication doses based only on a single set of results without medical guidance.
Methods and reference ranges vary by lab; thyroid cancer surveillance is most reliable when you trend results over time using the same lab and interpret thyroglobulin in the context of thyroglobulin antibodies.
Lab testing
Order the Tsn Thyroid Cancer Panel
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this panel with Vitals Vault
Vitals Vault makes it straightforward to order a multi-marker thyroid cancer surveillance panel without turning it into a weeks-long logistics project. You can use one order to collect the key thyroid function and tumor-marker-related labs that are typically interpreted together.
Once your results are in, you can review them as a set—because patterns matter. For thyroid cancer follow-up, the relationship between thyroglobulin and thyroglobulin antibodies can be as important as the absolute value, and thyroid hormone labs help explain symptoms and guide medication conversations.
If you want help making sense of mixed signals (for example: low TSH with normal free T4, or a thyroglobulin result that conflicts with your clinical story), PocketMD can walk you through what to ask next and what trends are usually monitored.
- Order a single lab panel instead of piecing together multiple separate tests
- Designed for trend-based monitoring (especially for thyroglobulin and antibodies)
- Optional PocketMD support to interpret your panel as a whole and plan follow-up testing
Key benefits of the Tsn Thyroid Cancer Panel
- Gives you a bundled view of thyroid hormone status and surveillance markers from one blood draw.
- Helps you interpret thyroglobulin in context by pairing it with thyroglobulin antibodies, which can distort tumor-marker readings.
- Supports trend monitoring over time, which is often more meaningful than a single isolated result in thyroid cancer follow-up.
- Clarifies whether symptoms are more consistent with under-replacement or over-replacement when you are taking thyroid hormone.
- Reduces “TSH-only” confusion by adding free hormone measurements that can explain discordant patterns.
- Flags autoimmune activity patterns (when antibody tests are included) that can complicate interpretation and symptom tracking.
- Creates a cleaner starting point for clinician conversations about imaging, dose adjustments, or add-on testing when results don’t align.
What is the Tsn Thyroid Cancer Panel?
The Tsn Thyroid Cancer Panel is a multi-biomarker blood test panel that groups together thyroid function tests and thyroid cancer surveillance-related markers that are commonly interpreted side-by-side.
A typical thyroid function “snapshot” includes thyroid-stimulating hormone (TSH) and free thyroid hormones (free T4 and sometimes free T3). These results help estimate whether your body is getting too much, too little, or an appropriate amount of thyroid hormone—either from your own thyroid gland or from thyroid medication.
For thyroid cancer surveillance, the most commonly used blood-based tumor marker is thyroglobulin (Tg). Tg is a protein made by thyroid tissue. After total thyroidectomy (and often after radioactive iodine), Tg is expected to be very low. A rising Tg trend can be a signal that thyroid tissue is present and may warrant follow-up, but interpretation depends heavily on your treatment history and on whether thyroglobulin antibodies (TgAb) are present.
TgAb can interfere with Tg measurement in many assays. That is why a surveillance-oriented panel often includes both Tg and TgAb, and why clinicians focus on trends (for example: Tg staying undetectable with stable negative antibodies, or TgAb rising even when Tg is low).
Depending on the exact build, a thyroid cancer-focused panel may also include additional thyroid antibodies (such as thyroid peroxidase antibodies, TPOAb) and/or total hormone measures. These can help explain autoimmune thyroid disease patterns and provide additional context when results are discordant or when you are planning pregnancy.
This panel does not replace imaging, pathology, or clinician follow-up. It is a lab-based tool that can support monitoring strategy, symptom context, and decisions about what to check next.
What do my panel results mean?
Patterns that can look “low” on this panel
In a thyroid cancer surveillance context, “low” often refers to very low or undetectable thyroglobulin (Tg) with negative or stable low thyroglobulin antibodies (TgAb), which is commonly reassuring after definitive treatment. On the thyroid function side, low free T4 (and/or low free T3) with a higher TSH pattern can fit under-replacement, missed doses, absorption issues, or a need to review your medication plan with your clinician. If Tg is low but TgAb is positive or rising, the key point is that Tg may be unreliable—your clinician may track TgAb trends and consider assay selection or follow-up testing rather than treating the Tg number as definitive.
Patterns that are often considered “optimal”
An “optimal” pattern depends on why you are testing. For many people on thyroid hormone, a stable TSH with free T4 (and free T3, if measured) in a consistent range—paired with stable symptoms—suggests your current dosing is working for you. For thyroid cancer surveillance, an optimal pattern is usually a stable trend: Tg remains undetectable or very low over time, TgAb is negative (or steadily declining if previously positive), and thyroid function results align with your clinician’s target (which may be more suppressed in higher-risk cancer follow-up). The most useful signal is consistency across repeat tests, not a single perfect value.
Patterns that can look “high” on this panel
A higher or rising thyroglobulin (Tg) trend can be a reason to follow up, especially after total thyroidectomy and when TgAb is negative (meaning the Tg measurement is more likely to be reliable). A high or rising TgAb can also be meaningful—sometimes as a sign of interference with Tg measurement, and sometimes as an immune trend your clinician will monitor alongside imaging and clinical context. On the thyroid function side, a low TSH with higher free T4 and/or free T3 can suggest over-replacement or increased thyroid hormone exposure, which can matter for symptoms (palpitations, anxiety, heat intolerance) and for longer-term risks if sustained. The “right” TSH target can differ in thyroid cancer surveillance, so interpretation should be individualized.
Factors that influence this panel (and can confuse interpretation)
Thyroid labs are sensitive to timing, medications, and assay effects. Biotin supplements can interfere with some immunoassays and may skew thyroid results; thyroid hormone dose timing (taking medication right before the draw) can temporarily raise measured hormone levels; and pregnancy or estrogen therapy can change binding proteins and shift total hormone results. For surveillance markers, the biggest confounder is thyroglobulin antibodies (TgAb), which can make Tg appear falsely low or otherwise unreliable depending on the method. Recent surgery, radioactive iodine, inflammation, and differences between labs/assays can also change results. Because of these variables, thyroid cancer monitoring is usually built around repeat testing, consistent lab methods when possible, and interpreting Tg and TgAb together rather than in isolation.
What’s included in this panel
- T3, Free
- Thyroglobulin Antibodies
- Thyroglobulin
- T4, Free
- T3, Reverse, Lc/Ms/Ms
Frequently Asked Questions
Do I need to fast for the Tsn Thyroid Cancer Panel?
Fasting is not usually required for thyroid function tests or thyroglobulin-related markers. The bigger issue is consistency: try to test at a similar time of day and discuss with your clinician whether to take thyroid medication before the draw, since taking it right beforehand can affect free hormone levels.
Why does this panel include both thyroglobulin and thyroglobulin antibodies?
Thyroglobulin antibodies (TgAb) can interfere with thyroglobulin (Tg) measurement in many lab methods. Testing both helps you and your clinician judge whether the Tg value is likely reliable and which trend (Tg, TgAb, or both) should be followed over time.
If my TSH is normal, why do I need free T4 and free T3?
TSH is a useful signal, but it is not the whole story—especially if you have symptoms, are taking thyroid hormone, or are in thyroid cancer follow-up where TSH targets may be intentionally lower. Free T4 and free T3 provide direct information about circulating active hormone levels and can clarify discordant patterns.
How should I read my results when some markers are “in range” and others are not?
Start by grouping results: (1) thyroid function (TSH, free T4/free T3, sometimes total hormones) and (2) surveillance markers (Tg and TgAb). Then look for patterns and trends rather than single numbers. A common example is low Tg with positive TgAb—this does not automatically mean “all clear” or “recurrence,” but it does mean Tg may be harder to interpret and trend strategy matters.
Can supplements or medications affect this panel?
Yes. Biotin can interfere with some thyroid immunoassays; thyroid hormone timing can shift free hormone levels; and certain medications (including amiodarone, steroids, and high-dose iodine exposure) can affect thyroid physiology and lab results. Share your medication and supplement list with your clinician when interpreting results.
Is it better to order this panel or order tests separately?
A bundled panel is often simpler when you know you need multiple components interpreted together (thyroid function plus surveillance markers). Ordering separately can make sense if you and your clinician are targeting a specific question (for example, a quick TSH check or a focused thyroglobulin follow-up), but it can also increase the chance that key context labs are missing.
What if my thyroglobulin result seems inconsistent with my history?
Inconsistencies can happen because of assay differences, antibody interference, timing after treatment, or lab-to-lab variability. Your clinician may recommend repeating the test using the same lab method, adding a HAMA-aware thyroglobulin option when appropriate, and interpreting results alongside imaging and your clinical course.